Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
| 34.18 Delayed Data As of Jun 29 |  +0.90 / +2.71%Today’s Change | 17.56 Today|||52-Week Range 44.46 | +46.76% Year-to-Date |
Latest AMPH News | Press Releases
No recent news for Amphastar Pharmaceuticals Inc.
Today’s Trading
| Previous close | 33.25 |
| Today’s open | 33.52 |
| Day’s range | 32.54 - 34.49 |
| Volume | 331,829 |
| Average volume (3 months) | 575,014 |
| Market cap | $1.6B |
Data as of 4:00pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | +4,262.75% |
| Earnings growth (this year) | +24.64% |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +25.13% |
| P/E ratio | 21.1 |
| Price/Sales | 2.65 |
| Price/Book | 3.51 |
Competitors
Data as of 4:00pm ET, 06/29/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $0.36 |
| Annual revenue (last year) | $437.8M |
| Annual profit (last year) | $62.1M |
| Net profit margin | 14.19% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rancho Cucamonga, California |
Forecasts
